Fast Feature Field: The missing link between event cameras and robot vision
Armored caterpillars offer robot designers lessons in crossing slippery glass
Speeding up planning decisions with AI
Robot Talk Episode 168 – Advancing robotics with novel electronics, with Zlatka Stoeva
Claire chatted to Zlatka Stoeva from DZP Technologies about flexible, stretchable and soft printed electronics for dexterous robots.
Zlatka Stoeva is a founder and managing director of DZP Technologies, a Cambridge-based company specialising in advanced materials and novel forms of electronics. Zlatka’s background is in materials chemistry, and she developed the innovative electronic materials which set the foundation for the company current portfolio of flexible, stretchable and soft electronics. DZP Technologies ventured into robotics during an ARIA-funded project, focused on printed electronics components for the dexterous robot.
Who Trains the Robots? What 1,196 Open Robot-Training Jobs Say About the Physical-AI Workforce
A computer scientist breaks through a limit that stood since 1996
The Role of Predictive Analytics in Shaping the Future of Healthcare
The Role of Predictive Analytics in Shaping the Future of Healthcare
How AI-Driven Predictive Modeling in Healthcare Helps for Personalized Treatment?
The health care industry is also making a paradigm shift with the facilitation afforded by advancements in AI technology and health information systems. One-size-fits-all solutions are being relegated to the backseat with the emergence of personalized medicine, with treatment tailored using the power of enormous volumes of health data.
Predictive modelling anchored on Artificial Intelligence (AI) is at the center of this revolution, an elevated methodology consisting of Machine Learning (ML) applications, current patient information, and physician knowledge to forecast outcomes. The technology is revolutionizing digital health solutions by giving the capacity to diagnose sooner, enhance treatment planning, and attain improved long-term outcomes.
The Role of Predictive Modeling in Personalized Healthcare
Predictive modeling in the health sector uses AI and ML algorithms to analyze massive quantities of genomic data, Electronic Health Records (EHRs), and real-time streaming sensor data from wearables to predict future health events. Conventional statistical models cannot learn from unstructured data (e.g., radiology images or clinical narrative), identify hidden patterns, or improve predictability over time.
-
Multimodal Healthcare Data Analytics
Multi-source health data is the key for AI models, all from EHRs, medical images, genomics, and wearable sensor data. Advanced ML models search through all this rich data to build treatment insights specific to a given patient.
For example, deep learning algorithms can analyze MRI scans, gene mutations, and patient information and suggest individualized oncology treatment administrations. IBM Watson Health is the best example that demonstrates predictive analytics healthcare augmentation of clinician judgment with unparalleled accuracy.
-
Real-Time Monitoring and Time-Series Prediction
AI and predictive analytics in digital health also perform well with real-time patient tracking. Real-time predictive algorithms match physicians and hospitals by monitoring physiological information such as heart rate, oxygen saturation, and blood pressure to identify anomalies and predict impending health emergencies.
-
Explainable AI (XAI) in Clinical Settings
With improvements in healthcare AI, transparency has never been more critical. Explainable AI provides clinicians immediate access to the reasoning behind the decision-making process, whether it’s the identification of the most important risk factors for disease or why one particular treatment is necessary. Such a trust-oriented focus is key to clinician adoption and regulatory approval of precision medicine AI technology.
-
Federated Learning for Secure AI Training
Personal data privacy is of the highest value in healthcare. Federated learning allows one to train AI models across decentralized data silos without compromising patient confidentiality. This keeps it under data governance and adds more to the availability of AI in healthcare data analysis.
Key Applications of AI Predictive Modeling in Personalized Healthcare
-
Early Diagnosis and Risk Stratification
Early disease diagnosis is the biggest application of predictive modeling. The scope of AI prediction in detecting early signs of diseases like cancer, cardiovascular disease, and neurological disease from EHR processing, lab data, and imaging studies weeks or months before presentations is enormous.
For example:
- AI machines forecast breast cancer through mammography with fairly accurate percentages, enabling early treatment.
- AI software calculates the chances of heart failure or diabetes in a patient and takes protective measures in advance.
Early diagnosis enhances prognosis, minimizes treatment stresses, and minimizes healthcare expenses.
-
Personalized Treatment Plans
Personalized treatment plans are now being prescribed by AI solutions based on individual patient’s profiles. They include:
- Choice of the right drug from a genetic match
- Optimization of optimal dosing
- Prediction of drug response or resistance
As an example, in treating cancer, AI systems take into account the genetics of the cancer to recommend customized chemotherapy regimens. AI-powered clinical advice aids practitioners in choosing drugs that are best suited for a patient’s medical history, rather than doing it through trial and error.
-
Chronic Disease Management
Asthma, diabetes, and hypertension are conditions that must be continuously monitored. AI predictive models can:
- Predict complications
- Enforce lifestyle modification
Real-time data are accurate and come from smartphone applications and wearable sensors. This data is input into AI models to derive insights into treatment planning, improving quality care management.
-
Reducing Hospital Readmissions
There is also predictive modeling to identify high-risk readmission patients. This data is utilized by the hospital in developing post-discharge care plans, telemedicine follow-up, and patient-specific education, thus enhancing patient outcomes and minimizing readmission penalties.
-
Genomic Data Integration for Precision Medicine
Genomics is also taking us to personalized medicine. Genomic sequence screening can be combined with AI for:
- Detection of disease-causing mutations
- Genetic risk prediction
- Targeting of cancer therapy
For example, predictive modeling aids in the choice of immunotherapy with genetic biomarkers like expression of PD-L1 in lung cancer.
-
Optimizing Clinical Trials
It will be a failure to enroll patients into clinical trials. AI makes it a success because:
- EHR and genotypic matching of potential enrollees
- Prediction of patient response to trial medications
- Prevention of dropouts Congestion-free reduction of trial duration and rapid-track new drug development.
Use Cases of Predictive Modeling in Healthcare
-
Oncology: Tailored Cancer Care
- Personalized Cancer Treatment: Predictive modeling is revolutionizing treatment and diagnosis in AI oncology solutions.
- Treatment Option: Based on disease history and gene markers, AI gives chemotherapy, targeted therapy, or immunotherapy to a patient with cancer.
- Radio Genomics: Machine learning integrates radiology images and genomics to forecast cancer aggressiveness and treatment response.
- Clinical Trial Matching: Predictive analytics identifies the patient and matches them to trials, and AI-assisted drug development is made possible.
-
Cardiology: Smart Heart Health Management
- AI models review ECG records, blood cholesterol readings, and patient histories to predict the likelihood of stroke or heart attack.
- Predictive modeling also powers virtual heart twins for test therapy simulation before use.
- AI-powered diagnosis of arrhythmia by wearable technology, the basis of remote patient monitoring solutions.
-
Neurology: Early Detection of Brain Disorders
Early detection and monitoring are made possible in neurology via AI by:
- MRI, genetic data, and behavioral patterns to identify Alzheimer’s and Parkinson’s.
- Stroke triage in minutes with AI tools such as Viz.ai, scanning for lethal blockages in the brain and alerting specialists in real-time.
These are only some of the many ways machine learning in medicine allows physicians to respond preventively.
-
Mental Health: Proactive Interventions
- Artificial intelligence-based Natural Language Processing (NLP) and sentiment analysis identify early depression, anxiety, or suicidal thoughts via social media, online conversations, and SMS.
- Predictive analytics also serve to assess the risk for chronic patients with bipolar disorders or schizophrenia.
-
Chronic Disease Management: Personalized Prevention
Predictive analytics is revolutionizing disease management of hypertension and diabetes. Some of the top applications are:
- Use of metabolic twins such as Twin Health to help with individualization of treatment and lifestyle for diabetic patients.
- Predicting non-adherence to drugs based on history of behavior, socio-economic status, and health literacy.
- MIPD-based CG dosing platforms enable patients to receive medication doses that are responsive to their genetic profile and the rate at which they metabolize.
Real-World Success Stories in AI-Powered Personalized Treatment
-
Predictive Oncology Enhancing Survival Rates
Predictive Oncology’s AI platform recently demonstrated improved survival prediction in ovarian cancer patients, supporting the potential of AI in personalized cancer therapy.
-
Sepsis Mortality Reduced with AI
UC San Diego Health recorded its COMPOSER program decreasing sepsis mortality by 17%. Real-world testing vindicates the potential for life-saving predictive modeling in critical care.
-
AI-Guided Cardiology
Machine learning technology used for coronary artery disease has prevented side effects and hospitalizations by detecting risk patients earlier than ever before.
-
Personalized Side Effect Prediction
The AI algorithm developed in the UK is able to predict three years later the likelihood of lymphedema among breast cancer survivors, promising a new era of individualized post-treatment possibility.
Benefits of AI Predictive Modeling in Healthcare
- Improved Accuracy: AI models are superior to traditional statistical methods in handling high-dimensional data. This improves diagnostic and treatment prediction accuracy.
- Scalability: AI models, once trained, can handle large amounts of data from diverse sources and scale across different departments, hospitals, or groups.
- Real-Time Insights: AI can enable ongoing, real-time insight into the patient’s situation so that action can be taken immediately.
- Cost Reduction: Prevention and anticipation of illness in advance save costs for treatment, prevent complications, and reduce hospitalization.
- Patient Empowerment: Individuals are offered personalized care plans and proactive management of health recommendations, and they become engaged participants in their own health process.
Future Trends: What’s Next for AI in Personalized Medicine
-
Digital Twins Across the Human Body
From heart to kidneys to pregnancies, digital models of patients will eventually enable simulation of disease progression and treatment response.
-
Predictive AI in Population Health
Not only patients, but predictive analytics will forecast disease epidemics, streamline hospital resource use, and support value-based care models at scale.
-
Generative AI in Drug Discovery
Generative Artificial Intelligence is speeding up drug discovery through protein structure prediction and drug interaction modeling, driving hyper-personalized care.
-
Blockchain in AI-Powered Health Systems
Health technology will ultimately meet up with decentralized technologies to provide secure and transparent management of individual healthcare data.
Conclusion
Put digital health, predictive analytics, and artificial intelligence technology together, and personalized medicine is a reality. In oncology, cardiology, neurology, mental health, and chronic care, AI enables clinicians to deliver care according to the unique profile of each patient. Over the next coming years, AI for health will augment but also foretell, adapt to, and customize, rewiring the patient experience around every bend.
Everyone claims AI governance now. 15 questions to test the claim.
“Governance” has become a fixture in enterprise AI announcements. Identity, security, orchestration, infrastructure, and data platform vendors offer products for agent safety, governance, and control, bringing welcome attention to a problem enterprises need to solve. As the claims grow broader, CIOs and risk leaders need to get more precise about what they are buying.
Look closely at those offerings and the capabilities differ. Some restrict an agent’s access, test how an agent behaves before launch, or collect records for an audit. Your exposure depends on how those capabilities connect and where their coverage ends. A vendor evaluation needs to show whether the controls cover your agents, apply your business rules, and keep working as both change.
One floor, no loop
Controls within that stack test behavior, restrict access, stop activity, and document outcomes. Each serves a necessary purpose, and each has boundaries that a governance claim should make clear.
The pattern to watch for is one floor and no loop: a useful capability presented as complete governance, with little clarity about what happens after deployment. A stack without a lifecycle is incomplete. Buyers need evidence that the controls will remain effective as agents, rules, and environments change.
Two gaps deserve particular attention.
- The first is a missing foundation: an incomplete view of which agents exist and what they can access. A platform might tightly control its registered agents while leaving agents that were never registered ungoverned. Those unknown agents can expose customer data without ever encountering the controls you evaluated.
- The second is a missing lifecycle. After an agent passes its launch review, someone may connect another tool, replace its model, or expand its permissions. Each change can affect behavior and protection. An unchanged approval says little about the agent’s current risk.
The lifecycle gap cuts both ways. A restriction introduced without testing can disrupt legitimate work, prompting a team to disable it to restore service. Governance must account for that pressure through testing, authorized changes, and checks that the protection still works.
A foundation and a continuous lifecycle
The foundation begins with a registry: a live record of every agent and what it is made of, including its model, tools, accounts it acts through, and data it can reach. When a sales agent gains access to another customer database, its owner should see the change and review the permissions involved.
Each agent also needs a distinct identity so investigators can trace its actions separately from its builder’s activity. With that foundation in place, governance becomes a loop that runs for as long as the agent does.
The lifecycle connects five stages throughout the agent’s use:
- Define sets the rules for the agent’s work, drawing on existing business obligations and risk decisions. For the sales agent, those rules specify which customer records it can use, which services it can contact, and which actions require approval.
- Test checks the agent against those rules before release and after relevant changes. A test should confirm that the sales agent can complete an approved customer request while resisting instructions to send protected records elsewhere.
- Enforce applies the rules while the agent works. A monitoring tool records a prohibited transfer and alerts security after the fact. An enforcement control prevents the transfer through the controlled route. Buyers need to know which actions the product can prevent and which it can only report.
- Prove preserves evidence of what happened and why. For the attempted transfer, that means identifying the agent, the rule that blocked it, and any approval or override that affected the decision.
- Adapt updates the controls as agents, requirements, and environments change. If the sales agent gains a new outside tool, its permissions need review and its protections need testing again. That change brings the process back through the loop.

15 questions to ask any AI governance vendor
These questions cover the full governance lifecycle, from the foundation that makes agents visible to the process that keeps them governed. No single vendor answers all 15 today, and any vendor that claims to is defining governance narrowly or selling you a roadmap. Your job isn’t to find a perfect score. It’s to evaluate coverage, direction, and architectural fit against your operating requirements.
Use these questions with every vendor. Ground the answers in your workflows and operating environments. Record what works today, what requires additional tools, and what your team will own after deployment. The answers labeled “flag” identify claims that deserve a closer look.
Foundation: agent registry and identity
1. Can you show us every agent we run, what each is made of, and when its ingredients change?
An agent can gain access to sensitive customer data after its original approval, leaving the business exposed to a change nobody reviewed. Ask for a registry that tracks models, tools, data access, and accounts, with changes reported to the responsible owner. Buyers may hear the ingredient list called an AI bill of materials (AI-BOM). Ask how agents built elsewhere enter the registry and how unregistered agents are found.
Flag: The vendor claims visibility into all your agents but is only describing agents built on their own platform.
2. Does each agent have its own identity, separate from the person who built it?
Agents that act through shared employee accounts leave investigators unable to distinguish an agent’s actions from a person’s decisions. Have the vendor show you how activity remains traceable when the builder changes roles or leaves.
Flag: Traceability depends on the builder’s account. If that person leaves or changes roles, the audit trail breaks.
Define: business rules and compliance requirements
3. Can we apply our existing rules and work with the risk and compliance tools we already use?
Separate rulebooks can leave risk leaders approving one restriction while agents operate under another. Ask how existing obligations reach agent controls and how evidence returns to the team’s current systems.
Flag: Integration means manual copying between systems, with no process to keep rules and evidence in sync.
4. Which regulatory frameworks come ready to use, and how does the evidence map to their requirements?
An audit can stall when activity records don’t answer a question about a specific requirement. Ask which obligations under the EU AI Act or recommendations in the NIST AI Risk Management Framework are supported. Request an example linking a requirement, its control, and supporting evidence.
Flag: The vendor claims logs are compliance-ready but can’t show which requirement a specific log entry satisfies.
Test: agent behavior and control effectiveness
5. How can we try to make an agent misbehave before launch?
Biased answers, invented information, or an agent manipulated through prompt injection can put customers at risk. Ask to see results from deliberate attempts to make the agent break its rules and whether a failed test blocks release.
Flag: The vendor shows passing results from standard tests but no evidence from deliberate attempts to break the agent.
6. What’s the plan when a rule change breaks something?
A restriction meant to protect customer data can cause an outage if it also blocks approved work. Ask how quickly the previous state can be restored, who is notified, and what the vendor does to isolate the rule change from running agents. Then ask what steps the vendor takes to reduce that risk before enforcement: staging, scoping the change to a subset of agents, or testing against recorded traffic.
Flag: The vendor’s only answer is to apply the change and watch for problems.
Enforce: prevention, boundaries, and exceptions
7. If our sales agent tries to send customer records to an outside tool, what stops it before the data leaves?
An alert after the transfer leaves you managing a data incident. Request a demonstration of prevention and a clear account of transfers the product can only report. Ask which controls or additional tools are needed for the workflow you run.
Flag: The vendor claims full visibility but can’t show what prevents the transfer, only what reports it.
8. Where do your controls sit, and what falls outside them?
A blocked transfer through one connection can still become a data incident if the agent reaches the same destination through another route. Ask the vendor to document where each control’s authority ends and what protection the buyer is responsible for beyond that boundary.
Flag: The vendor claims all traffic is governed but can’t identify which connections pass through the controls and which don’t.
9. What happens when a control fails or someone overrides it?
A failed control can expose data, while an unexplained shutdown can interrupt service. Ask whether the agent stops, continues, or seeks approval; who is notified; and how any override is authorized and recorded. Have the vendor explain what happens to work already in progress.
Flag: The vendor says an administrator can turn it off but can’t explain what happens to ongoing work or how that decision is recorded.
Prove: evidence and accountability
10. Can you explain an action or blocked attempt, including the agent, rules, and approvals behind it?
Boards and investigators need to understand why an action was permitted and who authorized exceptions. The record should identify the rule version and give reviewers enough context to judge whether the block was justified or interrupted legitimate work.
Flag: The log shows whether the action succeeded but not which rule applied or who approved the exception.
11. How would we know if a prevention control failed silently?
A team can believe it’s protected because alerts still fire, even when the blocking control behind them is down. Ask what evidence shows that prevention — not just detection — is still working, how a gap between the two reaches the responsible owner, and what the most recent verification looks like.
Flag: The vendor points to a green dashboard but can’t show evidence that prevention, not just monitoring, is operational.
Adapt: changes and authorization
12. When an urgent restriction is needed, what’s the fastest path to enforcement?
A critical restriction can be delayed when every change requires downtime or redeployment. Ask which updates take effect during operation and which require a maintenance window. Have the vendor walk through a time-sensitive scenario, blocking a newly discovered data exposure, for example, and explain how long enforcement takes from the moment you decide.
Flag: The vendor can’t walk through the steps or timeline for applying an urgent restriction.
13. Who can approve, change, or revoke an agent’s permissions, and is every change recorded?
Unclear authority can leave sensitive access in place after the business need ends. Ask for the approval trail, how an authorized owner can withdraw access, and when that withdrawal takes effect.
Flag: The vendor says the owner can remove access but can’t show who holds that authority or how revocation is recorded.
Across environments: consistency and portability
14. Do the same rules, controls, and evidence hold in our cloud, data center, and disconnected sites?
Uneven protection can leave a data center or remote site exposed under a policy that works in the cloud. Follow the same workflow through each environment. Ask what enforces the rule when outside services are unavailable, where records are stored, and how they reach the risk team later. Include agents built outside the vendor’s platform. Have the vendor identify what works today and what needs additional controls or rebuilding.
Flag: The vendor claims full cloud support but puts other environments on the roadmap.
15. How much depends on your infrastructure, and what can we take with us if we move?
A platform change can interrupt enforcement or make historical evidence difficult to use during an audit. Ask which rules, approvals, and records remain usable elsewhere, and which controls need replacement. Request an example of what can be exported and what your team would need to do to use it. If you replace the model or the framework used to build the agent, which rules and evidence remain valid, and what needs retesting?
Flag: The vendor says you can export your data but can’t show whether policies and audit records remain usable outside their platform.
Ask every vendor to document what its product doesn’t cover. An explicit limitation is something you can plan for. An unanswered question is unresolved risk.
Where single-environment governance stops
Governance built into the agent platform reduces integration work and keeps controls close to the agent. The question is how far that coverage reaches. Governance limited to one environment leaves your team responsible for protection beyond it.
Consider an insurer with a customer service agent in the cloud and claims data in its own data center. If it moves the agent into the data center or adds an agent built elsewhere, the test is whether the same rules, enforcement, and evidence follow. At disconnected sites, controls must work without outside services, with records kept locally until they can be transferred.
The insurer should set policy, own its evidence, and retain both when it changes infrastructure. Ask what remains usable and what needs rebuilding. Integrated governance should support your rules and your evidence across the environments where your agents run.
Establishing a standard for governed agents
A governed agent should have an identifiable owner, a current registry entry, and a traceable set of rules. Your organization should be able to show how those rules are tested and enforced, explain recorded decisions, and keep the process working as the agent changes. That standard applies wherever the agent operates.
The checklist sets a minimum evaluation standard for the complete governance process. An unanswered question identifies work that needs an owner, a control that needs to be supplied, or a deployment decision that deserves review. Vendors should make their contribution and limits clear enough for your team to act on them.
Begin with one agent that handles consequential data or actions, and follow it through the full lifecycle in the environments where it runs. Reviewing the evidence at each stage will show where your governance works and where exposure remains. The gap between claiming governance and running it is where enterprise risk lives.
See how DataRobot defines policy once and enforces it across the agent lifecycle.
The post Everyone claims AI governance now. 15 questions to test the claim. appeared first on DataRobot.